Home - Products - Others - Other Targets - Apigenin 6-C-alpha-L-arabinopyranosyl-8-C-beta-D-xylopyranoside

Apigenin 6-C-alpha-L-arabinopyranosyl-8-C-beta-D-xylopyranoside

CAS No. 677021-30-6

Apigenin 6-C-alpha-L-arabinopyranosyl-8-C-beta-D-xylopyranoside( —— )

Catalog No. M31614 CAS No. 677021-30-6

Apigenin 6-C-alpha-L-arabinopyranosyl-8-C-beta-D-xylopyranoside is a natural product from Viola yedoensis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 295 In Stock
10MG 396 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock

Biological Information

  • Product Name
    Apigenin 6-C-alpha-L-arabinopyranosyl-8-C-beta-D-xylopyranoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Apigenin 6-C-alpha-L-arabinopyranosyl-8-C-beta-D-xylopyranoside is a natural product from Viola yedoensis.
  • Description
    Apigenin 6-C-alpha-L-arabinopyranosyl-8-C-beta-D-xylopyranoside is a natural product from Viola yedoensis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    677021-30-6
  • Formula Weight
    534.47
  • Molecular Formula
    C25H26O13
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Guaiacin

    (+)-Guaiacin has significant neuroprotective, and anti-inflammatory activities, it can inhibit cyclooxygenase (COX)-1 and COX-2.

  • 5-Acetylsalicylic ac...

    Acetylsalicylic acid, also knows as aspirin, is an aminosalicylate anti-inflammatory drug used to treat inflammatory bowel disease.

  • pep2-SVKI

    Inhibitor peptide corresponding to last 10 amino acids of the C-terminus of the GluA2 AMPA receptor subunit. Disrupts binding of GluA2 (at the C-terminal PDZ site) with glutamate receptor interacting protein (GRIP), AMPA receptor binding protein (ABP) and protein interacting with C kinase (PICK1). Increases amplitude of AMPA receptor-mediated currents and blocks long-term depression (LTD).